Anti-B7-H3 Chimeric Antigen Receptor T-Cell (CAR-T Cell) Injection/TX103 Clinical Trials
2 recruitingBiologic
Phase 12
Showing 1–2 of 2 trials
Recruiting
Phase 1
Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.
High Grade GliomaWHO Grade Ⅳ Glioma
Tcelltech Inc.52 enrolled4 locationsNCT06482905
Recruiting
Phase 1
Phase I Study of TX103 CAR-T Cells in Participants With Advanced Solid Tumors
Solid Tumors
Tcelltech Inc.85 enrolled2 locationsNCT07231081